- Home
- About Us
-
Oncology
- BLADDER CANCER
- BRAIN TUMOR
-
BREAST CANCER
- Afinitor (Everolimus)
- Afinitor Disperz (everolimus)
- AROMASIN (exemestane) tablets
- ELLENCE (epirubicin hydrochloride)
- ENHERTU (trastuzumab-deruxtecan)
- FEMARA (letrozole)
- Ibrance (Palbociclib
- IXEMPRA (ixabepilone)
- KISQALI (Ribociclib)
- NERLYNX (Neratinib)
- NOLVADEX (tamoxifen citrate)
- ONTRUZANT (trastuzumab-dttb)
- PIQRAY (alpelisib)
- KADCYLA (ado-trastuzumab emtansine)
- LYNPARZA (olaparib)
- PALBACE (Palbociclib)
- PERJETA (Pertuzumab)
- PALBOCICLIB
- RIBOCICLIB
- PHESGO (pertuzumab-trastuzumab-hyaluronidase-zzxf)
- Talzenna (Talazoparib)
- TRAZIMERA (trastuzumab-qyyp)
- TRODELVY (Sacituzumab govitecan-hziy)
- TUKYSA (Tucatinib)
- TAXOTERE (Docetaxel)
- TYKERB (lapatinib)
- VIJOICE (alpelisib)
- ZINECARD (dexrazoxane)
- CERVICAL CANCER
- KIDNEY DISEASE
-
LUNG CANCER
- AVASTIN (bevacizumab)
- ALECENSA (Alectinib)
- ALIMTA (Pemetrexed)
- ALUNBRIG (Brigatinib)
- CRIZALK (Crizotinib)
- CYENDIV (nintedanib)
- ERLONAT (Erlotinib)
- GEFTINAT (Gefitinib)
- GILOTRIF (Afatinib)
- DACOPLICE (dacomitinib)
- HYCAMTIN (Topotecan)
- IRESSA Gefitinib
- IMFINZI (Durvalumab)
- LORBRENA (lorlatinib)
- LUMAKRAS (SOTORASIB)
- MEKINIST (Trametinib)
- NINTENA (Nintedanib)
- OFEV (Nintedanib)
- ORKAMBI (Lumacaftor/Ivacaftor)
- PORTRAZZA (Necitumumab)
- PEMNAT (Pemetrexed)
- ROZLYTREk (Entrectinib)
- TABRECTA (Capmatinib)
- TAGRISSO (Osimertinib)
- TECENTRIQ
- TRIKAFTA (elexacaftor/tezacaftor/ivacaftor)
- VARGATEF (Nintedanib)
- VIZIMPRO (Dacomitinib)
- XALKORI (crizotinib)
- THYROID CANCER
- SOFT TISSUE SARCOMA
-
Harmatology
-
BLOOD DISORDERS
- ANDEXXA (coagulation factor Xa (recombinant)
- ARANESP (darbepoetin alfa)
- EXJADE (deferasirox)
- ENJAYMO (sutimlimab-jome)
- Human Albumin Baxalta
- INREBIC (fedratinib)
- NYVEPRIA (pegfilgrastim-apgf)
- RETACRIT (epoetin alfa-epbx)
- SOTYKTU (deucravacitinib)
- SPEVIGO (spesolimab-sbzo)
- THALIX Thalidomide
- ULTOMIRIS (ravulizumab-cwvz)
- VONJO (pacritinib)
- BONE MARROW
- DERMATOLOGY
-
LEUKEMIA
- ADAKVEO (crizanlizumab-tmca) injection
- ATRIANCE (Nelarabine)
- Arzerra (Ofatumumab)
- BESPONSA (Inotuzumab ozogamicin)
- BLINCYTO (Blinatumomab)
- BOSULIF (Bosutinib)
- ERWINASE (Asparaginase)
- GLEEVEC (Imatinib)
- GLIVEC (Imatinib)
- VEENAT (Imatinib Mesylate)
- KYMRIAH (tisagenlecleucel)
- Idamycin idarubicin
- MAB CAMPATH (Alemtuzumab)
- MYLOTARG (gemtuzumab ozogamicin)
- NEUPOGEN (Filgrastim)
- NIVESTYM (filgrastim-aafi)
- ONCASPAR (Pegaspargase)
- ONUREG (azacitidine)
- PROMACTA (eltrombopag)
- RYDAPT (Midostaurin)
- SYNRIBO (Omacetaxine mepesuccinate)
- SCEMBLIX (asciminib) tablets
- TASIGNA (Nilotinib)
- Tibsovo (ivosidenib)
- VENCLEXTA (Venetoclax)
- VYXEOS (Daunorubicin and Cytarabine)
- XOSPATA (Gilteritinib)
- ZYDELIG (Idelalisib)
- LYMPHOMA
-
MELANOMA
- AGRYLIN (Anagrelide)
- DEFITELIO (Difibrotide)
- ELDISINE (Vindesine Sulphate)
- JAKAFI (Ruxolitinib)
- KIMMTRAK (tebentafusp-tebn)
- LIBTAYO (cemiplimab-rwlc)
- NPLATE (Romiplostim)
- MEKTOVI (binimetinib)
- Opdualag Nivolumab (relatlimab-rmbw)
- SARCLISA (isatuximab-irfc)
- TEPADINA (Thiotepa)
- TAFINLAR (dabrafenib)
- ZELBORAF (Vemurafenib)
- MULTIPLE MYELOMA
-
BLOOD DISORDERS
- Gastroenterology
- Influenza
-
Other Drugs
-
MISCELLANEOUS
- ADUCANUMAB
- OBETICHOLIC ACID
- ZOLEDRONATE
- BOTOX (Botulinum toxin)
- VIAGRA (Sildenafil)
- KAMAGRA GOLD (Sildenafil Citrate)
- SUHAGRA (Sildenafil Citrate)
- TADACIP (Tadalafil)
- eptinezumab-jjmr
- Cabotegravir/rilpivirine
- CYMEVENE (Ganciclovir)
- Eptinezumab-JJMR
- EMGALITY (Galcanezumab-gnlm)
- GUTRON (midodrine)
- Dextromethorphan / Bupropion
- ILARIS (canakinumab)
- KANUMA (sebelipase-alfa)
- Osilodrostat
- Rimegepant
- SOLIRIS eculizumabeculizumab)
- SOMAVERT (pegvisomant)
- Ubrogepant
- VISTIDE (Cidofovir)
- Vitrakvi (larotrectinib)
- XADAGO (safinamide)
- XERMELO (telotristat ethyl)
- ZOSTAVAX (zoster vaccine live)
- ZOLGENSMA (Onasemnogene abeparvovec-xioi)
- ASTHAMA
- CARDIOLOGY
- CROHN'S DISEASE
- DIARRHEA
- EYE
- FUNGAL DISEASE
- IMMUNE SYSTEM
- NEURO
- TRANSPLANT
- RHEUMATOID ARTHRITIS
- SPINE
- MULTIPLE SCLEROSIS
- TRANSPLANT MEDICATION
- HIV MEDICINES
- WEIGHT MANAGEMENT
-
MISCELLANEOUS
- FAQ
- Updates
- Contact Us
Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
ALKERAN (melphalan) Tablets, for oral use.
Available in India.
ALKERAN (melphalan) Tablets is used for the treatment of patients with multiple myeloma, ovarian. Brand ALKERAN (melphalan) Tablets can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.
What is Alkeran (Melphalan) used for?
Alkeran is used for Multiple myeloma, Ovarian cancer, Neuroblastoma, Rhabdomyosarcoma, Breast cancer treatment and also used in some conditioning regimens prior to bone marrow transplant
What is Melphalan used for?
Melphalan is a cancer medication that interferes with the growth and spread of cancer cells in the body. Melphalan is used to treat multiple myeloma (a type of blood cancer) and cancer of the ovary.
How much does Alkeran cost?
For procurement cost of Alkeran (Melphalan) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
Get In Touch
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in
Alkeran (Melphalan) suppliers in India
Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients Alkeran (Melphalan) can be made available to patients, doctors and hospitals at Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India.
For overseas patient Alkeran (Melphalan) brand in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Alkeran (Melphalan) In India
Dosage for & Strength
• For injection: 140 mg of Melphalan as a lyophilized powder in
a single-dose vial.
Get Access To ALKERAN (melphalan) Tablets In India
Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in multiple myeloma (a type of cancer of the bone marrow) treatment. Brand Name "ALKERAN (melphalan) Tablets" or Generic Name "melphalan Tablets" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.
